Inventor · disambiguated record
Gosse Jan Adema
Also filed as: ADEMA GOSSE · ADEMA GOSSE J · ADEMA GOSSE JAN
8 granted patents·17 pending applications·193 citations·filing 1995–2019
87Inventor score
Top patents by PatentIndex Score
25 records- 0192US6500919B1Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanomaINTROGENE BV·Filed 1995·Granted Dec 31, 2002·104 cites·6 claims
- 0289US6479638B1Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptorSCHERING CORP·Filed 2000·Granted Nov 12, 2002·19 cites·5 claims
- 0383US7999078B2Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptorSCHERING CORP·Filed 2008·Granted Aug 16, 2011·2 cites·24 claims
- 0483US7846450B2Melanoma associated peptide analogues and vaccines against melanomaUS HEALTH·Filed 2008·Granted Dec 7, 2010·3 cites·3 claims
- 0573US6140076AIg superfamily `dlair` receptors expressed in monocytesSCHERING CORP·Filed 1997·Granted Oct 31, 2000·21 cites·61 claims
- 0671US6573090B1Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectorsGEN HOSPITAL CORP·Filed 1999·Granted Jun 3, 2003·44 cites·29 claims
- 0767US2014141444A1Isolated Mammalian Monocyte Cell Genes; Related ReagentsADEMA GOSSE JAN·Filed 2014·Application pending·0 cites
- 0867US2005059808A1Isolated mammalian monocyte cell genes; related reagentsSCHERING CORP·Filed 2004·Application pending·0 cites
- 0967US2014141445A1Isolated Mammalian Monocyte Cell Genes; Related ReagentsADEMA GOSSE JAN·Filed 2014·Application pending·0 cites
- 1067US2004143858A1Isolated mammalian monocyte cell genes; related reagentsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1164US2013034561A1Isolated mammalian monocyte cell genes; related reagentsMERCK SHARP & DOHME·Filed 2012·Application pending·0 cites
- 1264US2003105303A1Isolated mammalian monocyte cell genes; related reagentsSCHERING CORP·Filed 2002·Application pending·0 cites
- 1362US2005287582A1Antibodies that specifically bind to FDF03SCHERING CORP·Filed 2005·Application pending·0 cites
- 1462US2004156861A1Melanoma associated peptide analogues and vaccines against melanomaFiled 2004·Application pending·0 cites
- 1562US2011256167A1Immunostimulating saponins for use in situ tumor-destruction therapySCHRIER CARLA CHRISTINA·Filed 2009·Application pending·0 cites
- 1662US2005142587A1Mammalian genes; related reagents and methodsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1761US2012020990A1Isolated mammalian monocyte cell genes; related reagentsADEMA GOSSE JAN·Filed 2011·Application pending·0 cites
- 1861US2009156786A1Mammalian Genes: Related Reagents and MethodsSCHERING CORP·Filed 2008·Application pending·0 cites
- 1957US8075900B2Melanoma associated peptide analogues and vaccines against melanomaFIGDOR CARL GUSTAV·Filed 2010·Granted Dec 13, 2011·0 cites·3 claims
- 2050US2010261190A1Mammalian Genes; Related Reagents and MethodsSCHERING CORP·Filed 2010·Application pending·0 cites
- 2146US2003216559A1Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanomaFiled 2002·Application pending·0 cites
- 2245US2009035300A1Immunomodulation of dendritic cellsADEMA GOSSE JAN·Filed 2006·Application pending·0 cites
- 2344US2016136197A1Pharmaceutical Compositions Comprising a GPG Oligodeoxynucleotide and Cyclic Di-GMPINTERVET INT BV·Filed 2014·Application pending·0 cites
- 2432US2004053391A1Renal cell carcinoma-antigen G250-derived peptides that elicit both CD4+ and CD8+ T-cell responsesUNIV NIJMEGEN·Filed 2002·Application pending·0 cites
- 2529US11639364B2Potent sialyltransferase inhibitorsSTICHTING RADBOUD UNIV·Filed 2019·Granted May 2, 2023·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →